AB Weblog: MIV Therapeutics Subsidiary Invited

September 08, 2006

MIV Therapeutics Subsidiary Invited to Present Groundbreaking Stroke-Prevention Device at Top International Symposium
RedNova - Aug 25 6:15 AM
MIV Therapeutics (OTCBB:MIVT) (FWB:MIV), a leadSave to My Web

AlphaTrade Reports Another Quarter of Record Revenue Growth
[Press Release] Business Wire via Yahoo! Finance - Aug 15 6:00 AM
VANCOUVER, British Columbia----Aug. 15, 2006--AlphaTrade.com has announced its financial results for second quarter ended June 30, 2006. All results are reported in US Dollars under accounting principles generally accepted in the United States of America .Save to My Web

MIV Therapeutics to Present Advanced Biocompatible Stent-Coating Technology at International Biomaterials Conference
[Press Release] Business Wire via Yahoo! Finance - Aug 15 1:01 PM
ATLANTA----Aug. 15, 2006--MIV Therapeutics , a leading developer of next-generation biocompatible coatings and advanced drug delivery systems for cardiovascular stents and other implantable medical devices, is scheduled present the highly encouraging development progress of the Company's Hydroxyapatite coatings for coronary stents and other devices at the 19th International Symposium on Ceramics Save to My Web

MIV Therapeutics to Present Advanced Biocompatible Stent-Coating Technology at International Biomaterials Conference;
RedNova - Aug 15 6:48 PM
MIV Therapeutics (OTCBB:MIVT)(FWB:MIV), a leadiSave to My Web

Posted by auctionbullet at September 8, 2006 07:13 AM